Pharmaceutical Executive
BMS is the first on what's bound to be a long list of opponents in the recent ruling on the definition of "average wholesale price."
Pharmaceutical Executive-11-22-2006
Pharmaceutical Executive
Genentech says Tanox acquisition does not signal a shift in strategy.
Pharmaceutical Executive
Industry points to new reports on Part D to blunt new Congressional critics.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
